Palini Gian Marco, Morganti Lucia, Paratore Filippo, Coccolini Federico, Crescentini Giacomo, Nardi Matteo, Veneroni Luigi
Department of General Surgery, Infermi Hospital, Rimini, Italy.
Department of General Surgery, Infermi Hospital, Rimini, Italy.
Int J Surg Case Rep. 2017;37:145-148. doi: 10.1016/j.ijscr.2017.06.005. Epub 2017 Jun 13.
The necessity to develop new treatment options for challenging procedures in hernia surgery is becoming even more evident and tissue engineering and biological technologies offer even newer strategies to improve fascial healing. The present case reports a patient-tailored surgical technique performed to repair a grade IV abdominal incisional hernia, with a combined use of platelet-rich plasma and bone marrow-derived mesenchymal stromal cells, implanted on a biological mesh.
A 71 year-old female patient complained of an abdominal incisional hernia, complicated by enterocutaneous fistula, four-months following laparostomy. Contrast enhanced computed tomography showed an incisional hernia defect of 15.5×20cm, with a subcutaneous abscess and an intestinal loop adherent to the anterior abdominal wall, with a concomitant enterocutaneous fistula. Surgery involved abdominal wall standardized technique closure, with in addition platelet-rich plasma and bone marrow-derived mesenchymal stromal cells implanted on a biological mesh. Two years follow up showed no recurrences of incisional hernia.
Coating surgical meshes with patient's own cells may improve biocompatibility, by reducing inflammation and adhesion formation. Moreover, platelet-rich plasma is a good source of growth factors for wound healing, as well as a good medium for bone marrow multinucleate cells introduction into fascial repair.
This approach is likely to improve abdominal wall repair in high grade (IV) incisional hernia, with the real possibility of improving prosthetic compatibility and reducing future recurrences. The authors agree with the necessity of further studies and trials to assure the safety profile and superiority of this procedure.
为疝修补术中具有挑战性的手术开发新的治疗方案的必要性日益明显,组织工程和生物技术提供了更新的策略来促进筋膜愈合。本病例报告了一种针对个体患者的手术技术,用于修复IV级腹部切口疝,联合使用富血小板血浆和骨髓间充质基质细胞,并将其植入生物补片。
一名71岁女性患者在剖腹术后4个月出现腹部切口疝,并伴有肠皮肤瘘。增强CT显示切口疝缺损为15.5×20cm,伴有皮下脓肿和一段肠袢粘连于前腹壁,同时存在肠皮肤瘘。手术采用腹壁标准化技术关闭,并在生物补片上植入富血小板血浆和骨髓间充质基质细胞。两年随访显示切口疝无复发。
用患者自身细胞覆盖手术补片可通过减少炎症和粘连形成来提高生物相容性。此外,富血小板血浆是伤口愈合生长因子的良好来源,也是将骨髓多核细胞引入筋膜修复的良好介质。
这种方法可能改善高级别(IV级)切口疝的腹壁修复,确实有可能提高假体相容性并减少未来复发。作者认同有必要进行进一步的研究和试验,以确保该手术的安全性和优越性。